Robot model
Sentire
Endoscopic surgical robotic system CE-marked under EU MDR in May 2026, covering general surgery, gynecology, thoracic, and urology.
- Manufacturer
- Cornerstone Robotics
- Form factor
- surgical
- Maturity
- pilot
- Lifecycle
- active
Verified profile
1
Sources on record
0
Tracked changes
Updated recently
Last verified change
Overview
Endoscopic surgical robotic system CE-marked under EU MDR in May 2026, covering general surgery, gynecology, thoracic, and urology. Clinical investigation ongoing at Portsmouth Hospitals NHS Trust; no FDA 510(k) filed for U.S. market.
Verified vs. claimed
- Maturity stage
- pilot(Small-scale deployment in controlled or trial conditions.)
- Verified deployments
- None on file
- Sources on file
- 1 source, view all
No verified deployments on file. DEPLOY tracks independently-sourced deployment evidence separately from manufacturer capability claims.
Safety record
No incidents on record for Sentire.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Sources (1)
Common questions
- What is Sentire?
- Endoscopic surgical robotic system CE-marked under EU MDR in May 2026, covering general surgery, gynecology, thoracic, and urology. Clinical investigation ongoing at Portsmouth Hospitals NHS Trust; no FDA 510(k) filed for U.S. market.
- Who makes Sentire?
- Sentire is made by Cornerstone Robotics, based in Hong Kong, founded in 2019.
- Where is Sentire deployed?
- No verified deployments of Sentire are currently on the DEPLOY registry. DEPLOY records deployments only when verified at a named site with a primary source; absence may reflect pre-deployment, research, or manufacturer-internal use.
- What is Sentire's maturity stage?
- Sentire is at the pilot stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Pilot stage means at least one named-customer trial deployment is verified.
- Is Sentire safe?
- Sentire has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 1 source (no primary) · last reviewed 2026-07-02
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-07-02
Maturity + lifecycle
Maturity stage: pilot
Lifecycle: active
Architectural position
Cohort: surgical
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Sentire.Machine-readable surfaces
- Markdown mirror: /models/sentire-surgical.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/models/b6033db9-6726-4005-8d0b-aae350a7789f
- Revision history: /models/sentire-surgical/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
DEPLOY Intelligence Score
0.0/ 100
Analysis
Thin deployment record; scale validation still in progress.
Signal flags
Dimension breakdown
Safety Record
Adoption Spread
IP Activity
Deployment Scale
Market Presence
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
Last computed: Jul 3, 2026
Intelligence layer